- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NPPA regulates prices of 81 medicines including off-patent anti-diabetic drugs
New Delhi: National Pharmaceutical Pricing Authority (NPPA) has fixed the price of 81 medicines including off-patent anti-diabetic drugs allowing due benefits of patent expiry to the patients.
NPPA has fixed the Retail Price of 'Insulin Human Injection, 200IU/ml' and '70% Isophane Insulin Human Suspension + 30% Insulin Human Injection 200IU/ml' for M/s Wockhardt Ltd at Rs. 106.65 per ml each (excluding GST) and 'Prasugrel Hydrochloride 10 mg (as film coated) + Aspirin 75 mg (as enteric coated) Capsule' for M/s Torrent Pharmaceuticals Ltd. at Rs. 20.16 per Capsule (excluding GST) with effect from 17.03.2021. Both the medicines were being sold at MRP of Rs. 132.50 per ml and at MRP of Rs. 27.26 per capsule respectively. With this price regulation, NPPA has re-assured availability of medicines at fair prices to public at large.
NPPA had granted price exemption for above mentioned formulations to the respective companies under Para 32 of the 'Drug Prices Control Order (DPCO), 2013 for a period of five years due to new drug delivery system developed through indigenous Research and Development. Price regulation was not applicable during the exemption period. NPPA in its meeting on 10.03.2021 decided to regulate the price of these formulations as per provisions of DPCO, 2013 as the exemption period has been over. This has resulted in reduction of the prices of Insulin Human Injection, 200IU/ml' and '70% Isophane Insulin Human Suspension + 30% Insulin Human Injection 200IU/ml', causing sizeable reduction over the existing prices. Now, these medicines have become more affordable to the public.
NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.
In addition, NPPA fixed ceiling price of 2 scheduled formulation namely Povidone Iodine 7.5% Scrub an anti-infective formulation and Levo-Thyroxine 37.5mg tablet used for treatment of Thyroid related diseases, causing considerable reduction to their present prices.
Revision in existing ceiling prices of scheduled formulations based on the Wholesale Price Index (WPI) was also approved by the Authority. The revised prices will be effective from April, 2021.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751